收稿日期: 2023-02-10
网络出版日期: 2023-09-26
基金资助
山东省医药卫生科技发展计划项目(2017WS412)
Hydrogen attenuates cardiomyocyte apoptosis after limb ischemia-reperfusion in rabbits via inhibition of TL1A/DR3 pathway
Received date: 2023-02-10
Online published: 2023-09-26
目的 探讨氢气通过肿瘤坏死因子样细胞因子1A(tumor necrosis factor-like cytokine 1A,TL1A)/死亡受体3(death receptor 3, DR3)通路对兔肢体缺血-再灌注后心肌细胞凋亡的影响。 方法 下载基因表达数据库(gene expression omnibus, GEO)GSE160516数据集,进行基因组百科全书(kyoto encyclopedia of genes and genomes, KEGG)通路富集。采用随机数字表法将18只雄性新西兰大耳白兔随机分为对照组(C组),肢体缺血-再灌注组(R组),氢气组(H组),每组6只。建立兔双后肢缺血-再灌注模型,各组动物取静脉血离心制备血清,摘取心脏。酶联免疫吸附试验(enzyme-linked immunosorbent assay, ELISA)法检测血清TL1A和DR3水平。终端脱氧核苷酸转移酶UTP介导的缺口端标记(terminal deoxynucleotidyl transferase UTP mediated nicked end labeling, TUNEL)法检测心肌细胞凋亡率。免疫印迹(western blotting)法测定心肌组织中TL1A、DR3与半胱氨酸天冬氨酸蛋白酶3(Caspase3)蛋白相对表达量。实时逆转录聚合酶链反应(real-time reverse transcription polymerase chain reaction, RT-qPCR)测定心肌组织中TL1A、DR3与Caspase3 mRNA相对表达量。 结果 KEGG通路富集分析发现,小鼠心肌缺血-再灌注后,基因表达富集在Apoptosis信号通路、TNF信号通路和MAPK信号通路等。实验观察到,与C组比较,R组血清TL1A和DR3表达水平显著升高(P < 0.01);与R组比较,H组血清TL1A和DR3表达水平显著降低(P < 0.01)。与C组比较,R组心肌细胞凋亡率显著升高(P < 0.01);与R组比较,H组心肌细胞凋亡率显著降低(P < 0.01)。与C组比较,R组心肌组织内TL1A、DR3和Caspase3蛋白与mRNA相对表达量均显著升高(P < 0.01);与R组比较,H组心肌组织内TL1A、DR3和Caspase3蛋白与mRNA相对表达量均显著降低(P < 0.05,P < 0.01)。 结论 氢气可通过抑制TL1A/DR3通路减轻肢体缺血-再灌注后心肌细胞凋亡。
李林 , 殷月 , 王晨晨 , 庄宝祥 , 王岱君 . 氢气抑制TL1A/DR3通路对兔肢体缺血-再灌注后心肌细胞凋亡的影响[J]. 实用医学杂志, 2023 , 39(16) : 2037 -2042 . DOI: 10.3969/j.issn.1006-5725.2023.16.005
Objective To investigate the effect of hydrogen on myocardiumapoptosis after limb ischemia-reperfusion in rabbits through inhibition of the tumor necrosis factor-like cytokine 1A (TL1A)/death receptor 3 (DR3) pathway. Methods The gene expression omnibus (GEO) GSE160516 dataset was downloaded and the kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment was performed. Eighteen male New Zealand large-eared white rabbits were randomly divided into control group (Group C), limb ischemia-reperfusion group (Group R), and hydrogen group (Group H) using the random number table method, with six rabbits in each group. The rabbit double hind limb ischemia-reperfusion model was established, and the animals in each group were centrifuged with venous blood to prepare serum, and the hearts were removed. Serum TL1A and DR3 levels were measured by enzyme-linked immunosorbent assay (ELISA). The terminal deoxynucleotidyl transferase UTP mediated nicked end labeling (TUNEL) assay was performed to detect apoptosis rate in myocardium. The relative expression of TL1A, DR3 and cysteine aspartate protease 3 (Caspase3) proteins in myocardium was measured by western blotting (WB). The real-time reverse transcription polymerase chain reaction (RT-qPCR) was performed to determine the relative expression of TL1A, DR3 and Caspase3 mRNA in myocardium. Results KEGG enrichment analysis revealed that gene expression was enriched to Apoptosis signaling pathway,TNF signaling pathway and MAPK signaling pathwayafter myocardium ischemia-reperfusion in mice. It was observed that the expression levels of serum TL1A and DR3 were significantly higher in group R compared with group C (P < 0.01), while the expression levels of serum TL1A and DR3 were significantly lower in group H compared with group R (P < 0.01). Compared with group C, the apoptosis rate of myocardium in group R was significantly higher (P < 0.01);compared with group R, the apoptosis rate of myocardium in group H was significantly lower (P < 0.01). The relative expressions of TL1A, DR3 and Caspase3 protein and mRNA in myocardium were significantly increased in group R compared with group C (all P<0.01); the relative expressions of TL1A, DR3 and Caspase3 protein and mRNA in myocardium were significantly decreased in group H compared with group R (P < 0.05, P < 0.01). Conclusion Hydrogen attenuates myocardium apoptosis after limb ischemia-reperfusion by inhibiting the TL1A/DR3 pathway.
Key words: hydrogen; ischemia-reperfusion; myocardium; apoptosis
| 1 | APICHARTPIYAKUL P, SHINLAPAWITTAYATORN K, RERKASEM K, et al. Mechanisms and Interventions on Acute Lower Limb Ischemia/Reperfusion Injury: A Review and Insights from Cell to Clinical Investigations [J]. Ann Vasc Surg, 2022, 86: 452-481. |
| 2 | OTHMAN M A, MUBARAK H A, SAYED M M. Ameliorative role of alpha-lipoic acid in renal cortical structural damage, induced by limb ischemia-reperfusion injury in the rat [J]. Ultrastruct Pathol, 2022, 46(1): 110-121. |
| 3 | YE Y, SHAN Y, BAO C, et al. Ginsenoside Rg1 protects against hind-limb ischemia reperfusion induced lung injury via NF-κB/COX-2 signaling pathway [J]. Int Immunopharmacol, 2018, 60: 96-103. |
| 4 | GOKALP O, EYGI B, GOKALP G, et al. Which Distant Organ is Most Affected by Lower Extremity Ischemia-Reperfusion?[J]. Ann Vasc Surg, 2020, 65: 271-281. |
| 5 | MATVEEV D V, KUZNETSOV M R, MATVEEV A D, et al. Reperfusion syndrome: state of the art [J]. Angiol Sosud Khir, 2020, 26(4): 176-183. |
| 6 | WANG L, DING Y, BAI Y, et al. The activation of SIRT3 by dexmedetomidine mitigates limb ischemia-reperfusion-induced lung injury [J]. Ann Transl Med, 2022, 10(6): 319. |
| 7 | YUAN T, YANG N, BI W, et al. Protective Role of Sulodexide on Renal Injury Induced by Limb Ischemia-Reperfusion [J]. Evid Based Complement Alternat Med, 2021, 2021: 6629718. |
| 8 | BERTHELOOT D, LATZ E, FRANKLIN B S. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death [J]. Cell Mol Immunol, 2021, 18(5): 1106-1121. |
| 9 | LI Z, YUAN W, LIN Z. Functional roles in cell signaling of adaptor protein TRADD from a structural perspective [J]. Comput Struct Biotechnol J, 2020, 18: 2867-2876. |
| 10 | YU Y, JIANG P, SUN P, et al. Analysis of therapeutic potential of preclinical models based on DR3/TL1A pathway modulation (Review) [J].Exp Ther Med, 2021, 22(1):693. |
| 11 | OHSAWA I, ISHIKAWA M, TAKAHASHI K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals [J]. Nat Med, 2007, 13(6): 688-694. |
| 12 | LI L, LI X, ZHANG Z, et al. Effects of Hydrogen-rich Water on the PI3K/AKT Signaling Pathway in Rats with Myocardial Ischemia-reperfusion Injury [J]. Curr Mol Med, 2020, 20(5): 396-406. |
| 13 | 李淑英, 李慧, 倪娟. 氢气对心肌缺血再灌注损伤的保护作用 [J]. 实用医学杂志, 2018, 34(15): 2618-2621. |
| 14 | 刘丹丹, 李林, 董云, 等. LIR损伤过程中腹腔给予氢气的兔血清TRAIL、Omi/HtrA2及骨骼肌组织Omi/HtrA2表达观察 [J]. 山东医药, 2021, 61(6): 36-39. |
| 15 | RITCHIE M E, PHIPSON B, WU D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies [J]. Nucleic Acids Res, 2015, 43(7): e47. |
| 16 | YU G, WANG L G, HAN Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters [J]. OMICS, 2012, 16(5): 284-287. |
| 17 | 崔昌胜, 庄宝祥, 吴洪娟, 等. 脉络宁注射液对兔肢体缺血/再灌注损伤TNF-α和NF-κB的影响 [J]. 中国药理学通报, 2019, 35(2): 295-296. |
| 18 | HEUSCH G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective [J]. Nat Rev Cardiol, 2020, 17(12): 773-789. |
| 19 | DEL RE D P, AMGALAN D, LINKERMANN A, et al. Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease [J]. Physiol Rev, 2019, 99(4): 1765-1817. |
| 20 | 张冰, 张静静, 蔺洛文, 等. 右美托咪定通过α_2AR/PI3K/Akt通路对大鼠肾缺血再灌注后心肌细胞凋亡的调控作用 [J]. 新疆医科大学学报, 2022, 45(11): 1237-1240,1247. |
| 21 | GELDI O, KUBAT E, üNAL C S, et al. Acetaminophen Mitigates Myocardial Injury Induced by Lower Extremity Ischemia-Reperfusion in Rat Model [J]. Braz J Cardiovasc Surg, 2018, 33(3): 258-264. |
| 22 | GONG S, LIU J, WAN S, et al. Schisandrol A Attenuates Myocardial Ischemia/Reperfusion-Induced Myocardial Apoptosis through Upregulation of 14-3-3θ [J]. Oxid Med Cell Longev, 2021, 2021: 5541753. |
| 23 | SONG Y, ZHANG Y, WAN Z, et al. CTRP3 alleviates myocardial ischemia/reperfusion injury in mice through activating LAMP1/JIP2/JNK pathway [J]. Int Immunopharmacol, 2022, 107: 108681. |
| 24 | FREUDE B, MASTERS T N, KOSTIN S, et al. Cardiomyocyte apoptosis in acute and chronic conditions [J]. Basic Res Cardiol, 1998, 93(2): 85-89. |
| 25 | NAGATA S. Apoptosis and Clearance of Apoptotic Cells [J]. Annu Rev Immunol, 2018, 36: 489-517. |
| 26 | ESKANDARI E, EAVES C J. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis [J]. J Cell Biol, 2022, 221(6):e202201159. |
| 27 | KOSHINUMA S, MIYAMAE M, KANEDA K, et al. Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury [J]. J Anesth, 2014, 28(2): 235-241. |
| 28 | NIE C, DING X, A R, et al. Hydrogen gas inhalation alleviates myocardial ischemia-reperfusion injury by the inhibition of oxidative stress and NLRP3-mediated pyroptosis in rats [J]. Life Sci, 2021, 272: 119248. |
| 29 | YANG M, DONG Y, HE Q, et al. Hydrogen: A Novel Option in Human Disease Treatment [J]. Oxid Med Cell Longev, 2020, 2020: 8384742. |
| 30 | QI C, WANG X, SHEN Z, et al. Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells [J]. Cell Res, 2018, 28(5): 544-555. |
| 31 | BITTNER S, KNOLL G, FüLLSACK S, et al. Soluble TL1A is sufficient for activation of death receptor 3 [J]. FEBS J, 2016, 283(2): 323-336. |
| 32 | CHEN X, GUO Y, LAI L, et al. Intracoronary and peripheral blood levels of TNF-like Cytokine 1A (TL1A) in patients with acute coronary syndrome [J]. Medicine (Baltimore), 2020, 99(22): e20305. |
| 33 | 陈新敬. TL1A及其受体DR3、DcR3在心肌缺血坏死中的作用及机制研究[D]. 广州: 南方医科大学, 2020. |
/
| 〈 |
|
〉 |